The Non-Executive of CB2 Insights (Other OTC: CBIIF) is Buying Shares

By Carrie Williams

Today, the Non-Executive of CB2 Insights (CBIIFResearch Report), Peter Cummins, bought shares of CBIIF for $37.5K.

Following this transaction Peter Cummins’ holding in the company was increased by 240% to a total of $52.75K.

See today’s analyst top recommended stocks >>

Based on CB2 Insights’ latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $3.7 million and GAAP net loss of -$661,741. In comparison, last year the company earned revenue of $3.26 million and had a GAAP net loss of $1.82 million. Currently, CB2 Insights has an average volume of 306.55K.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

CB2 Insights Inc has a mission to mainstream medical cannabis into traditional healthcare by gathering data and creating objective real-world evidence through proprietary software and service brands. Using clinical management and data collection software at the point-of-care, the company and its group of sub-brands has become a force behind bringing traditional healthcare protocols to the rapidly evolving cannabis industry.